Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma

被引:32
作者
Busam, KJ
Wolchok, J
Jungbluth, AA
Chapman, P
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Swim Across Amer Lab, New York, NY 10021 USA
[4] Ludwig Inst Canc Res, New York Branch, New York, NY USA
关键词
D O I
10.1111/j.0303-6987.2003.00154.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Diffuse melanosis is a rare event associated with advanced metastatic malignant melanoma. A 35-year-old woman with stage IV melanoma is presented, who developed slate bluish-gray to brown discoloration of her skin after chemotherapy-induced tumor lysis syndrome. A number of studies were performed to re-evaluate possible mechanisms of melanosis. Skin tissue was examined on routine hematoxylin-and-eosin-stained sections, Fontana stains, immunohistochemical studies with antibodies for Melan-A, gp100, tyrosinase, FXIIIa, and CD68, and by electron microscopy. The main cell types found to contain melanin pigment were histiocytes and dendritic cells. In the dermis, they were distributed mainly around venules. In the subcutaneous fat, they were scattered throughout the fat lobule. Melanin pigment was not only seen within cells but also extracellularly. No melanoma cells were seen in the skin. No increase in melanin pigment or number of melanocytes was seen in the epidermis. A bone marrow biopsy contained melanophages but no melanoma cells. Ultrastructural examination of the patient's serum revealed the presence of melanosomes. Sequence analysis of the tumor's cDNA failed to identify any mutations in the tyrosinase gene, and no tyrosinase protein was detected in non-melanocytic cells, indicating that it was unlikely that a mutation had resulted in a secretory form of the protein. These findings document that diffuse melanosis may result from tumor lysis, with release of melanosomes into the bloodstream.
引用
收藏
页码:274 / 280
页数:7
相关论文
共 30 条
[1]   DIFFUSE MELANOSIS SECONDARY TO METASTATIC MALIGNANT-MELANOMA - LIGHT AND ELECTRON-MICROSCOPIC FINDINGS [J].
ADRIAN, RM ;
MURPHY, GF ;
SATO, S ;
GRANSTEIN, RD ;
FITZPATRICK, TB ;
SOBER, AJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1981, 5 (03) :308-318
[2]   Diffuse melanosis arising from metastatic melanoma:: Pathogenetic function of elevated melanocyte peptide growth factors [J].
Böhm, M ;
Schiller, M ;
Nashan, D ;
Stadler, R ;
Luger, TA ;
Metze, D .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (05) :747-754
[3]   INDUCTION OF PIGMENTATION IN MOUSE FIBROBLASTS BY EXPRESSION OF HUMAN TYROSINASE CDNA [J].
BOUCHARD, B ;
FULLER, BB ;
VIJAYASARADHI, S ;
HOUGHTON, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (06) :2029-2042
[4]   Melan-A, a new melanocytic differentiation marker [J].
Busam, KJ ;
Jungbluth, AA .
ADVANCES IN ANATOMIC PATHOLOGY, 1999, 6 (01) :12-18
[5]   Expression of Melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma [J].
Busam, KJ ;
Chen, YT ;
Old, LJ ;
Stockert, E ;
Iversen, K ;
Coplan, KA ;
Rosai, J ;
Barnhill, RL ;
Jungbluth, AA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (08) :976-982
[6]  
Castro MP, 1999, CANCER, V85, P1055, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1055::AID-CNCR7>3.3.CO
[7]  
2-V
[8]   IMMUNOPHENOTYPING OF MELANOMAS FOR TYROSINASE - IMPLICATIONS FOR VACCINE DEVELOPMENT [J].
CHEN, YT ;
STOCKERT, E ;
TSANG, S ;
COPLAN, KA ;
OLD, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8125-8129
[9]  
ELDAR M, 1980, CUTIS, V25, P416
[10]   PATHOGENESIS OF GENERALIZED DERMAL PIGMENTATION SECONDARY TO MALIGNANT MELANOMA AND MELANURIA [J].
FITZPATRICK, TB ;
MONTGOMERY, H ;
LERNER, AB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1954, 22 (03) :163-172